Researchers have used whole genome analyses and chemogenetics to identify new drug targets and resistance genes in 262 parasite cell lines of Plasmodium falciparum -- protozoan pathogens that cause malaria -- that are resistant to 37 diverse antimalarial compounds.
More détails